The in vitro addition of methotrexate and/or methylprednisolone determines peripheral reduction in Th17 and expansion of conventional Treg and of IL-10 producing Th17 lymphocytes in patients with early rheumatoid arthritis

Title
The in vitro addition of methotrexate and/or methylprednisolone determines peripheral reduction in Th17 and expansion of conventional Treg and of IL-10 producing Th17 lymphocytes in patients with early rheumatoid arthritis
Authors
Keywords
Rheumatoid arthritis, Methotrexate, Steroid, IL-17, Treg, Th17
Journal
RHEUMATOLOGY INTERNATIONAL
Volume 35, Issue 1, Pages 171-175
Publisher
Springer Nature
Online
2014-05-02
DOI
10.1007/s00296-014-3030-2

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started